NES
ECTE

New England Securities’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

New England Securities’s Portfolio ECTE Stock Details ECTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$0 Hold
9
– – ﹤0.01% 1778
2014
Q3 		$0 Hold
9
– – ﹤0.01% 1812
2014
Q2 		$0 Hold
9
– – ﹤0.01% 1897
2014
Q1 		$0 Hold
9
– – ﹤0.01% 1876
2013
Q4 		$0 Buy
+9
New +$25 ﹤0.01% 1779

Other funds holding ECTE

PM
Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NPC
National Planning Corporation El Segundo, California $726K AUM 14.28% 1-Year Est. Return
EEG
E.E. Geduld $178M AUM 29.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

New England Securities's ECTE Position: Q4 2014 in Review

New England Securities held its ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) position steady in Q4 2014 at 9 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1778.

New England Securities first reported a position in ECTE in Q4 2013 and has held it in 5 quarters since. 17 funds tracked by Wall St. Rank hold ECTE as of Q4 2014.

  • New England Securities held 9 shares of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) worth $0 as of Q4 2014.
  • New England Securities left its ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) share count unchanged in Q4 2014.
  • ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) made up ﹤0.01% of New England Securities's portfolio in Q4 2014, its #1778 holding.
  • New England Securities first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q4 2013 and has held it in 5 quarters since.
  • 17 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.